MLchartDataset catalogue

Iratumumab

Term · Oncology and biomedicine · MLC-T-ONC-014567

A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers.

Table 1. Record
IdentifierMLC-T-ONC-014567
FieldOncology and biomedicine
SynonymsMDX-060; monoclonal antibody MDX-060
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014567",
  "term": "Iratumumab",
  "field": "Oncology and biomedicine",
  "definition": "A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers.",
  "synonyms": [
    "MDX-060",
    "monoclonal antibody MDX-060"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/iratumumab/"
}

Record 9,564 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.